Skip to content Skip to footer
Subscribe Now
Spotlight Interview_Michael Sassano
CXO TALKS

Spotlight Interview with Michael Sassano, CEO and Chairman of the Board for Somai Pharmaceuticals

On February 01, 2022, PharmaShots will present the second interview in its new interview section, “Spotlight- Company of the Month’’. Company of the month is our new exclusive feature under which we are interviewing the key leaders of the start-ups that are providing fierce solutions. We pick one company every month and interview them about…
January 27, 2022

Read more

Viewpoints_Ilse Eder
VIEWPOINTS

PharmaShots Interview: E&E CRO Consulting’s Ilse Eder Shares Insights on the Trends of Clinical Research & New Healthcare Technologies

In an interview with PharmaShots, Ilse Eder, CEO at E&E CRO Consulting shares her views on the breakthrough healthcare technologies to improve patient outcomes Shots: Principal Technologies is an investor in the MedTech space. Its first investment is an 80% stake in E&E which is focused on helping companies earn international distribution permits via clinical studies  Principal Technologies focuses on identifying…
January 25, 2022

Read more

Insights+: Key Takeaways of J.P. Morgan Healthcare Conference 2022 Based on Therapeutic Areas
INSIGHTS+

Insights+: Key Takeaways of J.P. Morgan Healthcare Conference 2022 Based on Therapeutic Areas

Shots: The 40th Annual J.P. Morgan Healthcare Conference took place virtually on Jan 10-13, 2022. The premier conference is the most extensive and most informative health care investment symposium in the Healthcare and pharma sector, which connects global leaders, emerging companies, innovative technology creators, and members of the investment community Considering the top biopharma companies…
January 19, 2022

Read more

Viewpoints_Thomas C. Corbridge
VIEWPOINTS

PharmaShots Interview: GSK’s Thomas C. Corbridge Shares Insights on the New Survey Data for Severe Eosinophilic Asthma Patients

In an interview with PharmaShots, Thomas C. Corbridge, US Senior Medical Lead at GSK shares his views on the new survey and demonstrated dissatisfaction with the asthma treatment paradigm Shots: The survey was commissioned by GSK and conducted by The Harris Poll in 100 patients aged ≥18yrs. showed that a majority of SEA patients and physicians are concerned about the current state…
January 18, 2022

Read more

Viewpoints_Nikki Longwell
VIEWPOINTS

PharmaShots Interview: Janssen’s Nikki Longwell Shares Insights on the National Biologic Coordinators Day

In an interview with PharmaShots, Nikki Longwell, Sr. Director, Medical Science Liaisons, Immunology at Janssen shares her views on the launch of the National Biologic Coordinators Day supporting the needs of people living with autoimmune diseases Shots: The company has launched the first national awareness day “National Biologic Coordinators Day” on Nov 1 which is also known as a day…
January 17, 2022

Read more

PharmaShots Interview Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine
VIEWPOINTS

PharmaShots Interview: Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine

In an interview with PharmaShots, Brian Ward, Medical Officer at Medicago shares his views on the P-III study of plant-based COVID-19 vaccine in combination with GSK’s pandemic adjuvant for the treatment of COVID-19  Shots: The company reported efficacy and safety results from the P-III study of Medicago’s plant-based COVID-19 vaccine candidate + GSK’s pandemic adjuvant in ~24,000 adults aged ≥18yrs. across Canada, US, UK,…
January 12, 2022

Read more

PharmaShots Interview Insmed’s Martina Flammer Shares Insights on New Affordable Drugs for Rare Diseases
VIEWPOINTS

PharmaShots Interview: Insmed’s Martina Flammer Shares Insights on New Affordable Drugs for Rare Diseases

In an interview with PharmaShots, Martina Flammer, Chief Medical Officer at Insmed share her views on the R&D continuum to develop new drugs for rare diseases and also highlights its business pillars Shots: The idea of the continuum is that all department works together to develop the drugs which will be helpful not only for the company but for patients too In…
January 11, 2022

Read more

Load more